Companies: 10,795·Total market cap: $144.5T
Medicus Sciences Acquisition Corp.

Medicus Sciences Acquisition Corp.

MSACNASDAQFinancial Services
$10.17
+$0.01(+0.05%)
Market Cap$0
P/E Ratio
52W High$10.18
52W Low$9.72

Medicus Sciences Acquisition Corp. (MSAC) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

msac · pe ratio · data through Dec 31, 2021

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Medicus Sciences Acquisition Corp. (MSAC) measures how much investors pay for each dollar of the company's trailing earnings. MSAC's current PE ratio of 55.33x is calculated by dividing its stock price of $10.17 by its TTM earnings per share of $0.18. +4.6% elevated vs 5Y avg 52.9x

55.33x
P/E Ratio (TTM)+4.6%

Source: FMP · /ratios-ttm · /analyst-estimates · 2021-12-31

Forward P/E
N/A
EPS (TTM)
$0.18
TTM · diluted EPS
PEG Ratio
0.19
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Medicus Sciences Acquisition Corp. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2020 – 2021 · Annual
PE Ratio (TTM)
5Y Avg 52.9x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Shell Companies · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Medicus Sciences Acquisition Corp.
Medicus Sciences Acquisition Corp.You
MSAC
55.33x+125.0%$0.18
Atlantic Coastal Acquisition Corp.
Atlantic Coastal Acquisition Corp.
ACAH
$127M24.00x-2.4%$0.42
26 Capital Acquisition Corp.
26 Capital Acquisition Corp.
ADER
$114M48.02x+95.2%$0.21
Crown Proptech Acquisitions
Crown Proptech Acquisitions
CPTK
$120MN/A$0.00
Juniper II Corp.
Juniper II Corp.
JUN
$130M14.40x-41.5%$0.71
Minority Equality Opportunities Acquisition Inc.
Minority Equality Opportunities Acquisition Inc.
MEOA
$114M7.48x-69.6%$1.39
Northern Star Investment Corp. II
Northern Star Investment Corp. II
NSTB
$0M29.10x+18.3%$0.34
Industry Average
5 peers with valid PE
24.60xbaseline

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 2 of 2 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2021-12-31Latest
FY2021
52.89x$0.18
2020-12-31
FY2020
$0.00

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Medicus Sciences Acquisition Corp. (MSAC) measures how much investors pay for each dollar of the company's trailing earnings. MSAC's current PE ratio of 55.33x is calculated by dividing its stock price of $10.17 by its TTM earnings per share of $0.18.

PE Ratio = Stock Price ÷ EPS (TTM)
= $10.17 ÷ $0.18 = 55.33x
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

MSAC pe ratio · 6 questions

MSAC's current PE ratio is 55.33x as of 2026-06-09, based on a stock price of $10.17 and TTM EPS of $0.18. Data sourced from Financial Modeling Prep via MSAC's SEC 10-K and 10-Q filings.

MSAC PE ratioWhat is MSAC PE ratioCurrent PE ratio of MSACMSAC PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Medicus Sciences Acquisition Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09